nVerses Capital’s Pediatrix Medical MD Stock Holding History

nVerses Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,100	Closed	-$31K	–	1241
2024 Q2	$31K	Buy	+4,100	New	+$33.9K	0.02%	689

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

nVerses Capital's MD Position: Q3 2024 in Review

nVerses Capital sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 4,100 shares — an estimated $31K sold.

nVerses Capital first reported a position in MD in Q2 2024 and held it in 1 quarter. The position peaked at $31K in Q2 2024. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

nVerses Capital reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 4,100 Pediatrix Medical shares in Q3 2024, an estimated $31K.
nVerses Capital first reported a position in Pediatrix Medical in Q2 2024 and held it in 1 quarter.
nVerses Capital's Pediatrix Medical position peaked at $31K in Q2 2024.
218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.